Apyx Medical Corporation (APYX) News
Track canonical SquawkNews coverage tagged to APYX, Apyx Medical Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Apyx Medical Initiated at Buy by Maxim Group
Ratings actions from Benzinga
NEWS | Sep 29, 2026, 04:46 PM UTC
L
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
Patients reported high satisfaction and visible improvements in skin elasticity, youthfulness, and radianceCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation NASDAQ:APYX (“Apyx Medical” or the
NEWS | Sep 29, 2026, 12:09 PM UTC
L
APYX: Driving growth in surgical aesthetics with innovative, FDA-cleared solutions and global reach
APYX: Driving growth in surgical aesthetics with innovative, FDA-cleared solutions and global reach
REGULATION | Aug 28, 2026, 12:54 PM UTC
L
Apyx Medical Affirms FY2026 Sales Guidance of $59.000M-$60.000M vs $59.554M Est
Apyx Medical (NASDAQ: APYX ) affirms FY2026 sales outlook from $59.000 million-$60.000 million to $59.000 million-$60.000 million vs $59.554 million estimate.
EARNINGS | Aug 06, 2026, 08:20 PM UTC